Liver Diseases  >>  Imjudo (tremelimumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Imjudo (tremelimumab) / AstraZeneca, Pfizer
NCT01008358 / 2008-001177-15: Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Checkmark P2 data
Apr 2012 - Apr 2012: P2 data
Completed
2
20
Europe
CP 675,206
Clinica Universidad de Navarra, Universidad de Navarra, Pfizer
Hepatocellular Carcinoma, Hepatitis C Virus Chronic Infection
05/12
05/12

Download Options